The Auryon System provides a laser‑based peripheral atherectomy platform that treats the full spectrum of peripheral arterial disease lesions with a single catheter. Its proprietary B‑Laser technology vaporizes plaque while preserving vessel integrity, reducing the need for multiple devices and lowering distal embolization risk.
Funding
$771K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with peripheral arterial disease (PAD) often present with heterogeneous lesions—including calcified plaques and in‑stent restenosis (ISR)—that require complex, multi‑device treatment strategies. Existing atherectomy tools can be cumbersome and carry a significant risk of distal embolization, limiting procedural confidence and outcomes.
Features
Feature details are not available yet.